期刊文献+

鬼臼乙叉甙对肺癌A549细胞生长特性及Fas/FasL表达的影响 被引量:2

Effects of Vp16 on the growth characteristics and Fas/FasL expression on human carcinoma A549 cells
暂未订购
导出
摘要 目的:研究Vp16对人肺腺癌A549细胞生长特性及Fas/FasL表达的影响。方法:用MTT法检测细胞增殖特性,FCM观察细胞周期及凋亡,RT-PCR测定mRNA表达的变化。结果:Vp16以时间和剂量依赖方式作用于A549细胞的增殖;不同浓度的Vp16作用A549细胞,使其阻断在不同的细胞周期,且均能明显下调FasL的mRNA的表达(P<0.05),而对FasmRNA的表达差异无显著性意义(P>0.05)。结论:Vp16直接作用A549细胞主要引起细胞坏死,Vp16可能通过下调FasL的mRNA的表达,防止肿瘤细胞免疫逃逸,该结果为临床合理联合用药提供了实验依据。 Objective:To investigate the effects of Vp16 on the growth characteristics and Fas/Fasl expression of A549 cells.Method:The growth rate, cell growth cycle and apoptosis were detected by MTr assay and FCM analysis respectively, The gene expression was determined by reverse transcription polymerase chain reaction (RT- PCR). Result:Vp16 inhibited the cell proliferation more effectively as dose and time increased. The cell cycle was arrested in dose-dependent manner, and FasLmRNA expression was dramatically decreased (P〈0.05), meanwhile Fas mRNA expression was not significantly different (P〉0.05) compared with the control. Conclusion:Vp16 cn mainly induce necrosis of human lung carcinoma A549 cells and prevent the immune escape of tumor cell by retarding FasLmRNA expression, which is valuable in selecting anti-cancer drugs in clinic therapy.
出处 《中国康复医学杂志》 CAS CSCD 北大核心 2006年第3期237-239,共3页 Chinese Journal of Rehabilitation Medicine
关键词 肺癌 鬼臼乙叉甙 FAS/FASL系统 免疫逃逸 细胞凋亡 lung carcinoma VP16 Fas/FasL system immune escape apoptosis
  • 相关文献

参考文献13

  • 1周军民,曹建国,廖端芳.鬼臼乙叉甙对人结肠癌细胞增殖和凋亡的影响[J].癌症,2000,19(4):328-330. 被引量:13
  • 2Rajashekhar G,Loganath A,Roy AC,et al.Co-expression of Fas (APO -1,CD95)/Fas liganath by Be Wo and NJG choriocarcinoma cell lines[J].Gynecol Oncol,2003,91 (1):101-111.
  • 3Bernstorff WV,Spamjaard RA,Chan AK,et al.Pancreatic cancer cells can immune surveillance via nonfunctional Fas (Apol/CD95) recepors and sberrant expression of functional Fas ligand[J].Surgery,1999,125(1):73-84.
  • 4Sejima T,Isoyama T,Miyagawa I.Alteration of apopototic regulatory molecules expression during carcinogenesis and tumor progression of renal cell carcinoma[J].Int J Urol,2003,10(9):476-484.
  • 5韩锐,陈晓光,周龙恩,等.抗肿瘤药物的分子药理学.见:周宏颖主编.分子药理学[M].哈尔滨:黑龙江科学技术出版社,1999.144-160.
  • 6Shimizu M,Kondo M,Ito Y,et al.Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients[J].Cancer Detect Prev,2005,29(2):175-180.
  • 7Dong Xilin,Dong Lei,Li Xiuxia,et al.The expression and clinical significance of fas and fasl in lung cancer[J].J Med University,2003,17(3):122-128.
  • 8Cho D,Song H,Kim YM,et al.Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates[J].Cancer Res,2000,60(10):2703-2709.
  • 9Li JH,Rosen D,Sondel P,et al.Immune privilege and FasL:two ways to inactivate effector cytotoxic T lymphocytes by FasL expressing cells[J].Immunology,2002,105(3):267-277.
  • 10Ken-Lchiro Seino,Nobuhiko Kayagaki,Ko Oku-Mura.Antitumor effect of locally produced CD95 ligand[J].Nature Medicine,1998,3:165-170.

二级参考文献9

共引文献14

同被引文献42

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部